Gilead Sciences Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery Second Genome will use its Microbiome Analytics platform to identify novel biomarkers linked to clinical responses to Gilead's investigational medicines. HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery Premium The international firm is one of several pharmaceutical companies emphasizing new single-cell technologies to improve existing drugs and find new ones. Biocartis, Kite Sign Development Agreement for Immunotherapy Assays The agreement is part of Biocartis' long term plans to expand its presence in the oncology field by building a menu of tests for immunotherapies. Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients Premium The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis. Yale, Gilead Extend Cancer Collaboration NEW YORK (GenomeWeb) – The Yale School of Medicine today said that it and Gilead Sciences have extended a research collaboration to identify the genetic and molecular bases of cancer. Mar 12, 2013 Cancer Genetics Partners with Gilead on CLL Clinical Trials; Revises Expected Proceeds from IPO Nov 16, 2012 SomaLogic, New England Biolabs, Gilead Sue Enzymatics for IP Infringement Dec 23, 2011 UCSF Researchers ID Peptides That May Dramatically Boost HIV Infection Rates Premium Mar 30, 2011 Yale-Gilead Partnership to Investigate Genetic, Molecular Basis of Cancer Jan 7, 2011 Movers & Shakers: Jan 7, 2011 Premium Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.